Medications for concurrent mental disorders among people with opioid use disorder: estimating adverse effects and the causal effect on opioid agonist treatment outcomes.
Medications for concurrent mental disorders among people with opioid use disorder: estimating adverse effects and the causal effect on opioid agonist treatment outcomes.
阿片类药物使用障碍患者并发精神障碍的药物治疗：估计不良反应以及对阿片类激动剂治疗结果的因果影响。
批准号：
416766
负责人：
Krebs Emmanuel
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-11-01 至 2022-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
More than half of Canadians seeking addiction treatment also have a mental disorder. In British Columbia, the prevalence of concurrent mental disorders among people with an opioid use disorder is as high as 74%. Sustained retention in opioid agonist treat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
